Zepbound® is a once-weekly injectable prescription option designed to support adults with obesity, or individuals who are overweight and have weight-related health conditions, in achieving and maintaining weight loss. It is intended to be used alongside a lower-calorie diet and increased physical activity. This medication combines GIP + GLP-1 activity to help regulate appetite, enhance feelings of fullness, and slow gastric emptying, which together support adherence and long-term results. The weekly dosing schedule also offers added convenience compared to daily treatments. Zepbound® contains tirzepatide and should not be taken with other products that include tirzepatide or with GLP-1 receptor agonists. Its safety and effectiveness when used with other prescription, over-the-counter, or herbal weight-loss products have not been established. It is also unknown whether it can be used in individuals with a history of pancreatitis, and it has not been approved for use in children under 18. Individual results may vary, and a prescription is required. For more details and full safety information, visit the official website: https://zepbound.lilly.com Medication is not included in the subscription price. Your subscription covers the clinical evaluation, prescribing services, and ongoing support. If prescribed, the cost of Wegovy®, Zepbound®, or any other medication will be billed separately by the pharmacy.